Year: 2014
Language: Setswana
Author(s): World Federation of Hemophilia
The 2021 edition is available in: English, Spanish, French, Arabic, Russian, Simplified Chinese
This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Farsi
This is not an official WFH translation. This resource has been translated with permission by a WFH National Member Organization (NMO), and is shared here with their kind permission. Translating organizations are encouraged to have translations reviewed by local experts, the WFH is not responsible for the translation or for any errors or changes to content from the original English edition. Patient organizations interested in translating a WFH resource must first obtain permission from the WFH, available here.
This patient handbook contains basic information about prophylaxis, the regular infusion of clotting factor concentrates in order to prevent bleeding. Prophylaxis is the goal of treatment for people with severe hemophilia, allowing them to remain active and participate more fully in daily life.
The previous edition of this resource has also been translated into the following languages, with permission from the WFH, by
Listen to this 2-hour webinar presented on July 27, 2021 to learn about global topics related to bleeding disorders. The
The currently evolving novel therapies for the management of hemophilia has ushered in a new era characterized by improved prophylaxis
In the Tuesday afternoon session entitled Prophylaxis: Global Models of Low-Dose Prophylaxis, Shashikant Apte presents the results of the implementation
The 2021 edition is available in: English, Spanish, French, Arabic, Russian, Simplified Chinese This resource has also been translated into the
